Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases

Clinical trial NCT07130786 · RECRUITING

Trial details

NCT number: NCT07130786
Sponsor: Ayal A. Aizer, MD
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Seizures Primary Motor Cortex Brain Metastases From Non-small Cell Lung Cancer (NSCLC)Brain Metastases, Adult Brain Metastases From Extra-cranial Solid Tumors

Start date: 2025-12-23
Primary completion: 2029-02-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.